UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Catherine C. Smith. Use of FLT3 Inhibitors in AML. Clinical Lymphoma Myeloma & Leukemia. 2019 Sep 1; 19:s92-s94.
Catherine C. Smith